November 3, 2017 / 10:38 AM / a year ago

BUZZ-Nicox: best day in over 5 years after FDA approves VYZULTA

** French biotech co up c23 pct in strong volume & set for biggest one-day rise in >5 yrs

** Nicox and Bausch + Lomb, wholly owned subsidiary of Valeant Pharmaceuticals, announced FDA gives green light to VYZULTA

** Cos say drug to be launched by the end of 2018 (8 months earlier than Invest Securities was expecting)

** Invest Securities raises Nicox PT by 7.7 pct to EUR 14, rating “buy”

** Stock best performer on CAC All Shares index and Health Care Financial Index

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below